Sanofi, a provider of diabetes devices, has opened a Lantus SoloSTAR Pen assembly plant in Beijing, china. The Lantus SoloSTAR plant with a capacity of 48 million units per year is designed to produce Lantus SoloSTAR pre-filled insulin ...
Tags: Sanofi, assembly plant, diabetes devices, Lantus SoloSTAR plant
Philosys, a contract design, development and manufacturing company, has obtained CE mark approval for its new Gmate SMART blood glucose monitor. By using the operating system of the smart phone, the patent pending technology of the Gmate ...
Tags: Philosys, Gmate SMART blood glucose monitor, Gmate SMART
Telcare has introduced a diabetes educator program to train diabetic patients how to use the company's wireless-enabled Blood Glucose Monitoring (BGM) system. The objective of diabetes educator program is to recruit and train a group of ...
Tags: Telcare, diabetes educator program
Telcare has launched new wireless Diabetes Pal app suite, designed for managing people with diabetes and improving self-management of blood glucose. The Diabetes Pal App for Android, which can be utilized by Telcare BGM and non-Telcare ...
Tags: Telcare, wireless Diabetes Pal app suite, Diabetes Pal App for Android
QuickMedical has announced the US launch of complete line of WaveSense blood glucose monitoring systems for detecting accurate blood glucose readings. The current use of glucose dehydrogenase pyrroloquinoline quinone (GDH PQQ) enzyme ...
Tags: QuickMedical, WaveSense blood glucose monitoring system
Dexcom has obtained CE mark approval for its new Dexcom G4 continuous blood glucose monitoring system. The Dexcom G4 system is designed to help diabetes patients to better manage their diabetes and control their glucose levels. Dexcom ...
Tags: Dexcom, CE mark approval, G4 system, diabetes, glucose levels
Echo Therapeutics has reported positive results from a clinical study of its Symphony tCGM system, designed to provide real-time blood glucose data continuously and cost-effectively. Designed as a non-invasive, wireless, transdermal ...
Tags: Echo Therapeutics, clinical study, Symphony tCGM system, CG-EGA
Roche has announced the US launch of ACCU-CHEK Combo system, designed for people with diabetes condition. The system, which combines a blood glucose meter with an insulin pump, utilizes Bluetooth technology for two-way wireless ...
Tags: diabetes therapy, clinical application, clinical technology
Roche's Accu-Chek Combo system has been cleared by the US Food and Drug Administration (FDA) for insulin pump therapy. The Accu-Chek Combo system features an insulin cartridge that can hold up to 315 units of insulin, as well as a ...
Simplex Healthcare has entered into collaboration agreement to provide PositiveID's iglucose system, designed for diabetes management. Under the agreement, Simplex will purchase iglucose units and will start trialing the iglucose ...
Tags: Diabetes Management System, clinical application, Simplex
Janssen Research & Development has submitted a New Drug Application (NDA) to the US FDA seeking approval for a fixed-dose therapy combining canagliflozin and immediate release metformin to treat patients with type 2 diabetes. ...
Nipro Diagnostics has entered into an agreement to integrate its TRUEresult blood glucose monitoring system into NextGen Healthcare Information Systems' Ambulatory electronic health record (EHR). The integration will help NextGen ...
Tags: Nipro, agreement, integration, monitoring system, EHR, TRUEresult system
Medtronic has obtained the CE mark approval for its Sentrino continuous glucose monitor (CGM), designed for use in hospital critical care units (CCU). Designed to optimize glucose management, the minimally invasive system displays ...
Tags: CGM, continuous glucose monitor, Medtronic, CCU
Janssen Research & Development has submitted a new drug application (NDA) to the FDA for canagliflozin to treat adult patients with type 2 diabetes. The filing is based on a global Phase III clinical development program, including nine ...
Tags: Janssen Research&Development, SGLT2, cardiovascular study
Teva Pharmaceutical Industries has unveiled authorized generic of Actos (pioglitazone-hydrochloride tablets) 15mg, 30mg and 45mg in the US. Actos is marketed by Takeda Pharmaceuticals USA and used with diet and exercise to improve blood ...